Literature DB >> 12376746

Molecular cloning and characterization of a novel human Rab ( Rab2B) gene.

Xiaohua Ni1, Yushu Ma, Haipeng Cheng, Min Jiang, Lingchen Guo, Chaoneng Ji, Shaohua Gu, Yueqong Cao, Yi Xie, Yumin Mao.   

Abstract

Rab proteins are small-molecular-weight guanosine triphosphatases (GTPases) that control vesicular traffic in eukaryotic cells. The small GTPase Rab2 is a resident of pre-Golgi intermediates and is required for protein transport from the endoplasmic reticulum to the Golgi complex. We identified a novel human Rab (Rab2B) gene that was 2312 bp in length and encoded a protein of 216 amino acid residues. The protein shared high homology with mouse Rab2 (identity 83%, similarity 91%). The expression pattern of the human Rab2B gene showed that there is a transcript in kidney, prostate, lung, liver, thymus, colon, pancreas, and skeletal muscle, and low levels in placenta, whereas specific bands of the transcript could not be detected in heart, brain, spleen, testis, ovary, small intestine, and leukocyte. Overexpression has been observed in colon adenocarcinoma CX-1. The Rab2B gene consists of nine exons and eight introns and is mapped to chromosome 14q11.1-14q11.2 by bioinformatics analysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376746     DOI: 10.1007/s100380200083

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  9 in total

Review 1.  The role of endocytic Rab GTPases in regulation of growth factor signaling and the migration and invasion of tumor cells.

Authors:  N Porther; M A Barbieri
Journal:  Small GTPases       Date:  2015-08-20

2.  Comparative Bioinformatics Analyses and Profiling of Lysosome-Related Organelle Proteomes.

Authors:  Zhang-Zhi Hu; Julio C Valencia; Hongzhan Huang; An Chi; Jeffrey Shabanowitz; Vincent J Hearing; Ettore Appella; Cathy Wu
Journal:  Int J Mass Spectrom       Date:  2007-01-01       Impact factor: 1.986

Review 3.  Consequences of Rab GTPase dysfunction in genetic or acquired human diseases.

Authors:  Marcellus J Banworth; Guangpu Li
Journal:  Small GTPases       Date:  2017-12-28

Review 4.  Rab GTPases implicated in inherited and acquired disorders.

Authors:  Shreya Mitra; Kwai W Cheng; Gordon B Mills
Journal:  Semin Cell Dev Biol       Date:  2010-12-13       Impact factor: 7.727

5.  Duplication 8q12: confirmation of a novel recognizable phenotype with duane retraction syndrome and developmental delay.

Authors:  Cyril Amouroux; Marie Vincent; Patricia Blanchet; Jacques Puechberty; Anouck Schneider; Anne Marie Chaze; Manon Girard; Magali Tournaire; Christian Jorgensen; Denis Morin; Pierre Sarda; Geneviève Lefort; David Geneviève
Journal:  Eur J Hum Genet       Date:  2012-01-18       Impact factor: 4.246

6.  MicroRNA-425 induces apoptosis and suppresses migration and invasion of human cervical cancer cells by targeting RAB2B.

Authors:  Yue Tian; Ying Luo; Jing Wang
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

7.  Identification of Ten-Gene Related to Lipid Metabolism for Predicting Overall Survival of Breast Invasive Carcinoma.

Authors:  Zhixing Wang; Fan Wang
Journal:  Contrast Media Mol Imaging       Date:  2022-07-11       Impact factor: 3.009

8.  RAB2A controls MT1-MMP endocytic and E-cadherin polarized Golgi trafficking to promote invasive breast cancer programs.

Authors:  Hiroaki Kajiho; Yuko Kajiho; Emanuela Frittoli; Stefano Confalonieri; Giovanni Bertalot; Giuseppe Viale; Pier Paolo Di Fiore; Amanda Oldani; Massimiliano Garre; Galina V Beznoussenko; Andrea Palamidessi; Manuela Vecchi; Philippe Chavrier; Frank Perez; Giorgio Scita
Journal:  EMBO Rep       Date:  2016-06-02       Impact factor: 8.807

Review 9.  Rab GTPases: Emerging Oncogenes and Tumor Suppressive Regulators for the Editing of Survival Pathways in Cancer.

Authors:  Priya D Gopal Krishnan; Emily Golden; Eleanor A Woodward; Nathan J Pavlos; Pilar Blancafort
Journal:  Cancers (Basel)       Date:  2020-01-21       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.